title: Overdose prevention for prisoners in New York: a novel program and collaboration.
abstract: This is a brief report on the establishment of a new program in New York State prisons to prepare prisoners to avoid the increased risks of drug overdose death associated with the transition to the community by training them in overdose prevention and making available naloxone, a medication that quickly reverses the effects of an opioid overdose, to all prisoners as they re-enter the community. It is a milestone collaboration in the USA between public health, the correctional system, and a community-based harm reduction program in response to the growth of heroin and opioid analgesic use and related morbidity and mortality, working together to get naloxone into the hands of the people at high risk of overdosing and/or of witnessing an opioid overdose.
authors.affiliation: New York State Department of Health, Corning Tower, Empire State Plaza, Albany, NY, 12237, USA. howard.zucker@healthny.gov.
authors.forename: Howard
authors.initials: H
authors.lastname: Zucker
authors.affiliation: New York State Department of Corrections and Community Supervision, The Harriman State Campus, Bldg. 2, 1220 Washington Avenue, Albany, NY, 12226-2050, USA. Anthony.Annucci@doccs.ny.gov.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Annucci
authors.affiliation: Harm Reduction Coalition, 22 W 27th St Fl 5, New York, NY, 10001, USA. stancliff@harmreduction.org.
authors.forename: Sharon
authors.initials: S
authors.lastname: Stancliff
authors.affiliation: New York State Department of Health AIDS Institute, 90 Church Street, 13th floor, New York, NY, 10007, USA. holly.catania@yahoo.com.
authors.forename: Holly
authors.initials: H
authors.lastname: Catania
mesh_terms: D003299:Cooperative Behavior; D062787:Drug Overdose / Q000517:prevention & control*; D040261:Harm Reduction; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009518:New York; D009293:Opioid-Related Disorders / Q000150:complications*; D011329:Prisoners; D015397:Program Evaluation
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone